Learn more about how Peptide Receptor Radionuclide Therapy (PRRT) can improve care for Neuroendocrine Tumor patients. Another effective illustration of how Radiotheranostics work and its application in the field of oncology.
Watch video >>
Other news & events
- News04.08.2026

Virtual Radiotheranostics Summit: Expanding Access to Targeted Cancer Care Across Africa
Read more - News29.07.2026

TerraPower Isotopes Collaborates with Oncidium Foundation to Donate Actinium-225, Expanding Cancer Treatment Access
Read more - News01.07.2026

Türkiye Introduces Reimbursement for Actinium-225 PSMA Therapy
Read more




